<DOC>
	<DOCNO>NCT00380939</DOCNO>
	<brief_summary>This study design assess effect coronary artery plaque use aggressive lipid-lowering therapy versus moderate lipid-lowering therapy . A substudy examine effect treatments brachial artery vasoactivity .</brief_summary>
	<brief_title>This Study Uses Ultrasound Determine Whether Atorvastatin Pravastatin Effects Progression Coronary Plaque .</brief_title>
	<detailed_description />
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<criteria>Angiographic evidence coronary artery disease define lesion least 20 % reduction luman diameter visual ( angiographic ) estimation native coronary artery . LDL cholesterol equal 125mg/dl 210mg/dl . Patients anticipated undergo coronary bypass surgery cardiac transplantation course study . Known major hematologic , neoplastic , metabolic , gastrointestinal endocrine dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>